In a phase 2b trial, danicamtiv, a novel cardiac myosin activator, was well tolerated and associated with improved heart ...

Dilated cardiomyopathy (DCM) occurs when the ventricles of the heart dilate and weaken, reducing the heart’s ability to pump enough blood. DCM is a severe heart condition that often begins in the left ...

The heart’s main pumping chamber, the left ventricle, becomes weaker, stretched, and larger in people with dilated cardiomyopathy (DCM). This makes it harder for the heart to pump blood effectively.

Scientists at the CNIC and Hospital Universitario Puerta de Hierro in Majadahonda have developed a software application that predicts the likelihood that a case of dilated cardiomyopathy is caused by ...

Genetic predisposition to dilated cardiomyopathy may elevate likelihood of developing secondary cardiomyopathies related to ...

An international team, led by scientists from the Victor Chang Cardiac Research Institute has studied around 3000 people affected by the heart disease dilated cardiomyopathy (DCM) – a driver of heart ...

Pregnant women with dilated cardiomyopathy (DCM) face high risks of complications and maternal death due to haemodynamic ...

More than a quarter of adults receiving specialized care for idiopathic dilated cardiomyopathy (DCM) had parents, siblings, or children with the disorder, particularly among those who were Black, in ...